NASDAQ · ZENA

ZenaTech, Inc.

$1.32 -$0.06 (-4.71%) 1D Market open

Key Metrics

$122.66M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$43.43M
Beta · 1Y 2.16
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 21
    From its Jan 30 high, the share price fell 63%.

    Peak close $3.38 on Jan 30; trough close $1.24 on May 21. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -63%
  • May 15
    The stock moved -28.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 15
  • Apr 30
    The stock moved +14.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$122.66M
Enterprise value$119.96M
Shares outstanding88.9M
52-wk range$1.15 – $7.11
Avg volume · 20D2.7M
Net cash $2.70M
Book value / share$0.76
ExchangeNASDAQ
About ZenaTech, Inc.
IPO dateOct 1, 2024
Employees17

ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver solutions across diverse industries. The company operates in software development technology, sales, and distribution.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio2.22
Quick ratio2.03
Debt / equity0.05
Debt / EBITDA
Net cash $2.70M
Working capital$18.25M

Cash Flow · TTM

Operating CF −$35.46M
Capex −$7.97M
Free cash flow −$43.43M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings